A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer
Jazz Pharmaceuticals
Jazz Pharmaceuticals
Merck Sharp & Dohme LLC
NGM Biopharmaceuticals, Inc
TG Therapeutics, Inc.
Dartmouth-Hitchcock Medical Center
SWOG Cancer Research Network
National Institutes of Health Clinical Center (CC)
CONKO-Studiengruppe